A significant driver of top-line growth: Aquestive Therapeutics Inc (AQST)

With 1.4 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.71 million shares. The 52-week range on AQST shows that it touched its highest point at $6.23 and its lowest point at $2.24 during that stretch. It currently has a 1-year price target of $9.86. Beta for the stock currently stands at 2.68.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AQST was down-trending over the past week, with a drop of -5.36%, but this was down by -14.24% over a month. Three-month performance dropped to -39.64% while six-month performance fell -37.50%. The stock lost -36.75% in the past year, while it has lost -25.56% so far this year. A look at the trailing 12-month EPS for AQST yields -0.52 with Next year EPS estimates of -0.56. For the next quarter, that number is -0.16. This implies an EPS growth rate of -29.63% for this year and 15.04% for next year. EPS is expected to grow by 13.68% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 27.90%.

Float and Shares Shorts:

At present, 91.41 million AQST shares are outstanding with a float of 87.68 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AQST since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$0.4268 being high and -$0.44576 being low. For AQST, this leads to a yearly average estimate of -$0.43628. Based on analyst estimates, the high estimate for the next quarter is -$0.13 and the low estimate is -$0.2. The average estimate for the next quarter is thus -$0.16.